Effect of Spinal Anesthesia in Elective Cesarean Cases on Frontal QRS Angle in Anemic and Non-Anemic Patients
Comparison of the Effect of Spinal Anesthesia Applied in Elective Cesarean Cases on Frontal QRS Angle in Anemic and Non-Anemic Patients
1 other identifier
observational
100
1 country
1
Brief Summary
The QRS-T angle represents a novel marker of myocardial repolarisation. It is defined as the angle difference between the direction of ventricular depolarisation (QRS wave) and the direction of ventricular repolarisation (T wave). It is an indicator of instability in the electrophysiological properties of the myocardium and is associated with arrhythmias. The frontal QRS-T angle is a straightforward, cost-effective parameter that can be readily obtained from 12-lead electrocardiography. The most prevalent arrhythmias during pregnancy are atrial arrhythmias. However, ventricular tachyarrhythmias are exceedingly rare during pregnancy and may be life-threatening. Caesarean section is one of the most common surgical procedures. General anaesthesia, spinal anaesthesia and epidural anaesthesia can be employed in these patients. Spinal anaesthesia is a frequently employed method in caesarean section operations due to its rapid onset of effect, technical simplicity of application and higher probability of success. In pregnant women, anaemia is defined as a haemoglobin concentration below 11 mg/dL in the first trimester, 11 mg/dL in the second trimester and 10.5 mg/dL in the third trimester.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2024
CompletedFirst Submitted
Initial submission to the registry
May 22, 2024
CompletedFirst Posted
Study publicly available on registry
May 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2024
CompletedMay 30, 2024
May 1, 2024
4 months
May 22, 2024
May 22, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
The measurements to be taken include QRS, frontal QRS, QRS angle and Tp-e interval. (T1)
preoperatively
The measurements to be taken include QRS, frontal QRS, QRS angle and Tp-e interval.(T2)
after spinal anaesthesia
The measurements to be taken include QRS, frontal QRS, QRS angle and Tp-e interval.(T3)
5 min after spinal anaesthesia
The measurements to be taken include QRS, frontal QRS, QRS angle and Tp-e interval.(T4)
5 min after spinal anaesthesia
The measurements to be taken include QRS, frontal QRS, QRS angle and Tp-e interval.(T5)
10 min after spinal anaesthesia
Study Arms (2)
Patients who had undergone Elective Cesarean Surgery with anemia
In pregnant women, haemoglobin values below 11 mg/dL in the first trimester, 11 mg/dL in the second trimester and 10.5 mg/dL in the third trimester indicate anaemia. The group comprised patients with haemoglobin levels below 10.5 mg/dL.
Patients who had undergone Elective Cesarean Surgery without anemia
In pregnant women, haemoglobin values below 11 mg/dL in the first trimester, 11 mg/dL in the second trimester and 10.5 mg/dL in the third trimester indicate anaemia. The group comprised patients with haemoglobin levels above 10.5 mg/dL.
Eligibility Criteria
The study will include 100 patients aged 18-45 years with an American Society of Anesthesiologists (ASA) II classification who will undergo elective caesarean section.
You may qualify if:
- Aged 18-45 years
- Patients with American Society of Anesthesiologists (ASA) II classification
You may not qualify if:
- Patients with rhythm disorders
- Patients with electrolyte disturbances
- Patients with liver and/or renal failure
- Obese patients (body mass index \> 30)
- Trauma patients
- Cancer patients
- ASA III-IV patients
- Patients who do not wish to participate in the study will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Health Science Turkey Sanliurfa Mehmet Akif Inan Training and Research Hospital
Sanliurfa, 63050, Turkey (Türkiye)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant professor
Study Record Dates
First Submitted
May 22, 2024
First Posted
May 30, 2024
Study Start
April 20, 2024
Primary Completion
August 31, 2024
Study Completion
August 31, 2024
Last Updated
May 30, 2024
Record last verified: 2024-05